Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / ADS
-
Total 13F shares
-
19,008,902
-
Share change
-
+801,721
-
Total reported value
-
$1,905,348,717
-
Put/Call ratio
-
137%
-
Price per share
-
$100.25
-
Number of holders
-
164
-
Value change
-
+$64,667,972
-
Number of buys
-
80
-
Number of sells
-
81
Institutional Holders of GW PHARMACEUTICALS PLC - ADS (GWPH) as of Q2 2017
As of 30 Jun 2017,
GW PHARMACEUTICALS PLC - ADS (GWPH) was held by
164 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
19,008,902 shares.
The largest 10 holders included
Capital Research Global Investors, SCOPIA CAPITAL MANAGEMENT LP, PRUDENTIAL PLC, FMR LLC, Viking Global Investors LP, PRICE T ROWE ASSOCIATES INC /MD/, JANUS HENDERSON GROUP PLC, Capital World Investors, BANK OF AMERICA CORP /DE/, and ORBIMED ADVISORS LLC.
This page lists
164
institutional shareholders reporting positions in this security
for the Q2 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.